Biocon Biologics
Shreehas Tambe has a vast experience in the pharmaceutical industry, with a background in chemical technology and bioprocess technology. Shreehas has held various executive positions at Biocon and Biocon Biologics, such as CEO, President, COO, and Senior Vice President. Shreehas has extensive experience in managing development, manufacturing operations, commercialization, and investment projects in different countries. Shreehas has also been involved in scaling up processes, leading teams, and implementing new technologies in production facilities. With a strong academic background and years of hands-on experience, Shreehas is a seasoned professional in the pharmaceutical industry.
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics